tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market
Advertisement

Marksans Pharma Limited (MARKSANS) Ratios

Compare
3 Followers

Marksans Pharma Limited Ratios

IN:MARKSANS's free cash flow for Q4 2025 was ₹0.54. For the 2025 fiscal year, IN:MARKSANS's free cash flow was decreased by ₹ and operating cash flow was ₹0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.62 4.78 4.78 4.91 3.37
Quick Ratio
2.85 3.19 3.19 3.49 2.18
Cash Ratio
1.48 1.03 1.03 1.12 0.97
Solvency Ratio
0.58 0.65 0.65 0.75 0.55
Operating Cash Flow Ratio
0.00 0.59 0.59 0.70 0.28
Short-Term Operating Cash Flow Coverage
0.00 7.92 7.92 5.71 2.40
Net Current Asset Value
₹ 14.54B₹ 12.67B₹ 12.67B₹ 12.50B₹ 7.84B
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.09 0.09 0.06 0.07
Debt-to-Equity Ratio
0.13 0.12 0.12 0.07 0.09
Debt-to-Capital Ratio
0.12 0.11 0.11 0.07 0.08
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.31 1.30 1.30 1.26 1.36
Debt Service Coverage Ratio
11.46 9.94 9.94 6.43 5.14
Interest Coverage Ratio
40.35 69.55 69.55 31.52 39.72
Debt to Market Cap
<0.01 <0.01 <0.01 0.01 0.02
Interest Debt Per Share
7.45 5.63 5.63 3.18 2.84
Net Debt to EBITDA
-0.70 -0.31 -0.31 -0.65 -0.78
Profitability Margins
Gross Profit Margin
56.87%49.75%49.75%50.25%49.46%
EBIT Margin
17.30%19.97%19.97%18.72%17.09%
EBITDA Margin
20.47%23.38%23.38%21.52%20.32%
Operating Profit Margin
22.52%35.78%35.78%15.54%14.47%
Pretax Profit Margin
17.36%19.45%19.45%18.23%16.72%
Net Profit Margin
13.20%14.41%14.41%14.38%12.47%
Continuous Operations Profit Margin
13.26%14.46%14.46%14.33%12.62%
Net Income Per EBT
76.03%74.07%74.07%78.87%74.57%
EBT Per EBIT
77.11%54.36%54.36%117.35%115.60%
Return on Assets (ROA)
10.81%11.70%11.70%12.16%11.25%
Return on Equity (ROE)
15.32%15.19%15.19%15.26%15.35%
Return on Capital Employed (ROCE)
21.62%34.01%34.01%15.56%16.68%
Return on Invested Capital (ROIC)
16.17%24.70%24.70%11.86%11.94%
Return on Tangible Assets
11.20%12.17%12.17%12.80%11.90%
Earnings Yield
4.57%4.38%4.38%9.11%9.91%
Efficiency Ratios
Receivables Turnover
4.91 4.80 4.80 -454.74 3.75
Payables Turnover
3.74 4.08 4.08 4.00 3.74
Inventory Turnover
1.35 1.77 1.77 1.90 1.76
Fixed Asset Turnover
2.96 3.14 3.14 4.79 4.32
Asset Turnover
0.82 0.81 0.81 0.85 0.90
Working Capital Turnover Ratio
3.07 1.55 1.55 1.70 2.04
Cash Conversion Cycle
246.59 192.60 192.60 99.88 206.83
Days of Sales Outstanding
74.32 75.97 75.97 -0.80 97.35
Days of Inventory Outstanding
269.82 206.12 206.12 192.03 207.11
Days of Payables Outstanding
97.55 89.49 89.49 91.35 97.63
Operating Cycle
344.14 282.09 282.09 191.23 304.46
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 5.08 5.08 5.72 2.42
Free Cash Flow Per Share
0.00 0.48 0.48 4.42 1.29
CapEx Per Share
0.00 4.61 4.61 1.29 1.13
Free Cash Flow to Operating Cash Flow
0.00 0.09 0.09 0.77 0.53
Dividend Paid and CapEx Coverage Ratio
0.00 1.00 1.00 3.72 1.74
Capital Expenditure Coverage Ratio
0.00 1.10 1.10 4.43 2.14
Operating Cash Flow Coverage Ratio
0.00 0.94 0.94 1.93 0.90
Operating Cash Flow to Sales Ratio
0.00 0.11 0.11 0.13 0.07
Free Cash Flow Yield
0.00%0.30%0.30%6.28%2.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.88 22.83 22.83 10.98 10.09
Price-to-Sales (P/S) Ratio
2.90 3.29 3.29 1.58 1.26
Price-to-Book (P/B) Ratio
3.11 3.47 3.47 1.68 1.55
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 332.07 332.07 15.91 35.19
Price-to-Operating Cash Flow Ratio
0.00 31.09 31.09 12.32 18.76
Price-to-Earnings Growth (PEG) Ratio
-2.74 2.87 2.87 0.26 -0.46
Price-to-Fair Value
3.11 3.47 3.47 1.68 1.55
Enterprise Value Multiple
13.44 13.76 13.76 6.69 5.41
Enterprise Value
72.97B 70.03B 70.03B 26.65B 16.27B
EV to EBITDA
13.44 13.76 13.76 6.69 5.41
EV to Sales
2.75 3.22 3.22 1.44 1.10
EV to Free Cash Flow
0.00 324.69 324.69 14.50 30.74
EV to Operating Cash Flow
0.00 30.40 30.40 11.22 16.39
Tangible Book Value Per Share
52.55 43.71 43.71 39.86 27.71
Shareholders’ Equity Per Share
54.57 45.55 45.55 42.01 29.37
Tax and Other Ratios
Effective Tax Rate
0.24 0.26 0.26 0.21 0.25
Revenue Per Share
58.67 48.03 48.03 44.59 36.16
Net Income Per Share
7.75 6.92 6.92 6.41 4.51
Tax Burden
0.76 0.74 0.74 0.79 0.75
Interest Burden
1.00 0.97 0.97 0.97 0.98
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
0.00 <0.01 <0.01 <0.01 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.73 0.73 0.70 0.40
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis